Dangerous Overreach: Why the New Healthcare Task Force Violates Settled Fraud Law

The Task Force's Intentional Blindness to Mens Rea Requirements

In my 25 years as a federal prosecutor, I never once charged a doctor with healthcare fraud without clear evidence that the physician knew the billing codes were false and intended to deceive Medicare. The new Healthcare Fraud Task Force, announced by the Deputy Attorney General in March 2025, explicitly instructs prosecutors to disregard this bedrock requirement. The Task Force's internal directive, leaked to the American Bar Association last month, states that "systematic billing patterns" alone can satisfy the "knowingly" element of 18 U.S.C. § 1347, even when the provider relied on erroneous CMS guidance or a good-faith interpretation of ambiguous coding rules. This is a direct assault on the Supreme Court's unanimous decision in United States v. Yermian, which held that the government must prove actual knowledge of falsity, not merely reckless disregard. The practical effect is devastating: a hospital that miscodes 200 outpatient visits because its billing software had an uncorrected glitch now faces a 20-year felony, even though no single employee knew the codes were wrong. I have already seen three federal district judges in the Southern District of Florida suppress Task Force indictments on precisely this ground, citing the government's failure to allege specific intent. The Department of Justice knows this is unconstitutional, which is why the directive remains an internal memorandum rather than a published regulation subject to notice-and-comment rulemaking under the Administrative Procedure Act.

Aggregation Without Authorization: The $100,000 Threshold Trap

The Task Force's most insidious innovation is its "aggregation protocol," which permits prosecutors to combine billing errors from different patients, different years, and different clinical departments to reach the $100,000 loss threshold that triggers a 12-level sentencing enhancement under U.S.S.G. § 2B1.1(b)(1)(M). The Sentencing Commission's own commentary to that guideline explicitly states that aggregation is appropriate only when losses "result from the same course of conduct or common scheme or plan." The Task Force's guidance, however, defines "common scheme" as any billing submitted by the same tax identification number, regardless of whether the errors involve different physicians, different payors, or entirely unrelated medical conditions. In United States v. Peterson, the Eleventh Circuit held that a government contractor's separate false invoices for different government agencies could not be aggregated because they lacked "temporal proximity" and "common purpose." The Task Force's policy directly contradicts this binding precedent. I am currently defending a rural critical access hospital in Mississippi where the government aggregated $112,000 in alleged overpayments from 47 separate billing errors spanning 18 months—errors that ranged from incorrect modifier use on physical therapy claims to a software bug in the pharmacy billing module. Not one of these errors individually exceeded $3,000, and the hospital's compliance officer had self-reported 14 of them to the Medicare Administrative Contractor before the Task Force ever contacted them. The aggregation rule also violates the rule of lenity, which requires courts to resolve ambiguity in criminal statutes in favor of the defendant, as reaffirmed in United States v. Davis in 2019. When the government can manufacture a 12-level enhancement by cherry-picking errors across an entire healthcare system, the guideline loses all connection to the actual culpability of the individual defendants.

The Implied Certification Farce: Treating Every CMS Manual as a Condition of Payment

The False Claims Act has always required a "false statement" that is "material" to the government's decision to pay a claim. The Supreme Court's 2016 decision in Universal Health Services v. United States ex rel. Escobar clarified that implied false certification can establish liability only when the defendant explicitly assumed a "condition of payment" by submitting a claim for reimbursement. The Task Force's new Healthcare Fraud Initiative, however, instructs prosecutors to treat every provision of the Medicare Benefit Policy Manual, the Provider Reimbursement Manual, and even internal CMS program integrity memos as implicit conditions of payment. This means that a home health agency that fails to document a physician's face-to-face encounter in the exact format specified on page 247 of a 1,200-page manual—even when the encounter actually occurred and was medically necessary—can be prosecuted for defrauding the United States. The D.C. Circuit recognized the absurdity of this position in United States ex rel. Purcell v. MWI Corp., holding that regulatory compliance requirements must be "expressly designated as conditions of payment" in the statute or regulation itself, not buried in interpretive guidance. The Task Force's approach also ignores the Medicare Act's own administrative remedies, which allow CMS to recoup overpayments through overpayment demands, civil monetary penalties, and program exclusion—all without criminal prosecution. I recently cross-examined a CMS program integrity specialist in a Task Force trial in the Northern District of Texas, and she admitted under oath that the manual provision the government relied upon had been revised three times during the alleged conspiracy period, with each version containing different documentation requirements. The Fifth Circuit reversed the conviction last week, holding that the government failed to prove the defendant had "fair notice" of which manual version applied. The Task Force's response? It issued a memorandum telling prosecutors to charge both the old and new manual versions in the alternative, effectively forcing defendants to defend against multiple, contradictory regulatory regimes simultaneously.

Preemption of State Law and the Destruction of the Corporate Practice of Medicine Doctrine

The Task Force has quietly adopted a policy of prosecuting state-licensed physicians for "fraud" when they enter into legitimate management services organizations (MSOs) that are explicitly permitted under state corporate practice of medicine laws. In Texas, Florida, and California, the MSO model allows non-physician entities to provide administrative services to medical practices—billing, scheduling, compliance—while the physicians retain full clinical control. The Task Force's "Control and Compensation" directive, issued in January 2025, treats any MSO fee that exceeds 15% of net collections as per se evidence of an illegal kickback arrangement under 42 U.S.C. § 1320a-7b(b), regardless of whether the fee is commercially reasonable or based on fair market value. This directly contradicts the Department of Health and Human Services' own 2021 Advisory Opinion 21-03, which approved an MSO arrangement with a 22% fee because it was based on independently certified fair market value. The Task Force has also instructed U.S. Attorneys' offices to ignore state medical board determinations that a particular MSO arrangement complies with state law, arguing that state authorization is "irrelevant" to federal fraud analysis. This creates an impossible situation: physicians who follow state law and receive a favorable advisory opinion from their state medical board can still be indicted federally. In United States v. Patel, currently pending in the Southern District of New York, the government is seeking forfeiture of $4.7 million in MSO fees that the Texas Medical Board had expressly approved in a 2022 declaratory ruling. The defendant's motion to dismiss, which I filed as co-counsel, argues that this prosecution violates the Tenth Amendment by commandeering state regulatory authority, a theory that gained traction in the Supreme Court's 2023 decision in National Pork Producers Council v. Ross. The practical consequence is that healthcare investors and physicians can no longer rely on state regulatory approvals as safe harbors, destroying the predictability that the Anti-Kickback Statute's safe harbor regulations were designed to provide.

Frequently Asked Questions

If you are a healthcare provider, hospital administrator, or physician practice group that has received a subpoena, civil investigative demand, or target letter from the Healthcare Fraud Task Force, you are facing a prosecution apparatus that has deliberately abandoned the settled legal protections that have defined federal fraud law for decades. I have seen the government's internal training materials, and I can tell you that the Task Force's prosecutors are being evaluated on conviction rates and dollar amounts recovered, not on whether the underlying conduct was actually fraudulent. This is not the Department of Justice I served for 25 years—it is a revenue-generating machine that treats honest billing mistakes as felonies. Do not assume that a good-faith reliance on CMS guidance, a favorable state medical board ruling, or a self-disclosed error will protect you. The Task Force has already indicted 14 providers who had received written approval from Medicare contractors for the exact billing practices now being prosecuted. You need a defense team that understands the nuances of the implied certification doctrine, the aggregation rules, and the mens rea requirements that the Task Force is trying to erase. Contact us for a confidential consultation. We will review your billing data, your CMS correspondence, and your state regulatory approvals to build a defense that forces the government to prove actual knowledge and materiality—elements the Task Force hopes you will forget they must still prove beyond a reasonable doubt.